{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"OT Clinical Advisory Editor for Hematology\/Oncology Mikkael Sekeres, MD, MS","description":"Dr. Sekeres, Director of the Leukemia Program at the Cleveland Clinic Taussig  Cancer Institute and Chair of the Hematology\/Oncology Pharmacy &amp;amp;  Therapeutics Committee, discusses his particular research interests of  myelodysplastic syndromes and acute myelogenous leukemia, including the overlaps  between the two in older adults, new opportunities to better define MDS  epidemiologically in the US, and new treatment approaches.","author_name":"OT Broadcast News","author_url":"http:\/\/www.oncology-times.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/1110568\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/1110568"}